What are the symptoms of mold exposure?
The symptoms with settled evidence behind them are respiratory and allergic: stuffy nose, sore throat, cough, wheeze, burning eyes, and skin rash. Asthma gets worse in people who already have it. What a symptom list cannot do is tell you whether your building has mold. That question is answered by looking for water, and the two are worth keeping apart.
Which mold symptoms have settled evidence behind them
CDC's list is short and it is the right place to start: a stuffy nose, sore throat, coughing or wheezing, burning eyes, or skin rash. Severe reactions occur in people who have asthma or a mold allergy, and lung infections can occur in people who are immunocompromised. Everything on that list is airway or allergy.
The Institute of Medicine's 2004 review of damp indoor spaces reached the same shape from the evidence side. It found sufficient evidence of association for upper respiratory symptoms, cough, wheeze, asthma symptoms in people who already have asthma, and hypersensitivity pneumonitis in susceptible individuals.
A 2011 systematic review updating that work added asthma development, allergic rhinitis, and eczema to the list, and described the evidence for asthma exacerbation in children as strongly suggestive of causality. It also found there is not sufficient epidemiologic evidence of a causal relationship for any of the reviewed health outcomes.
That pair of statements is not a contradiction. Association is well established across many studies and many countries. Causation, at the level a review will certify, is not, and the honest way to hold both is that damp moldy homes and these symptoms travel together reliably enough to act on the dampness.
Two mechanisms sit outside the allergy story and are worth naming because they are less common and more serious. Repeated exposure to a heavily contaminated system, an air handler rather than a bathroom corner, can drive hypersensitivity pneumonitis, a delayed inflammation of the lung. And in people whose immune systems are suppressed, certain species can cause invasive infection rather than an allergic reaction.
Why the same house affects two people differently
Three things decide whether a given person reacts to a given amount of indoor mold, and none of them is a property of the house: whether they are sensitized to the particular fungi present, whether they already have asthma, and whether they are susceptible to hypersensitivity pneumonitis. Sensitization to common indoor genera is real and unevenly distributed, so two people in one damp room can have different experiences of it.
No home mold test measures any of the three. A sample tells you what is growing on a wall. It cannot tell you whether the person standing next to that wall makes antibodies against it, which is the variable that decides the response.
That is why the risk groups are described by person rather than by concentration. People with asthma, people with a diagnosed mold allergy, people with chronic lung disease, and people who are immunocompromised carry more risk from the same exposure than people who are not in those groups.
It also explains something households often read as evidence. If one person in a house feels unwell and nobody else does, that pattern is compatible with a mold problem and equally compatible with no mold problem at all. It is a fact about immune systems, not a diagnostic test in either direction.
What about black mold and toxic mold?
Black mold usually refers to Stachybotrys chartarum, and its real significance is what it indicates rather than what it emits: the species is associated with sustained water damage, so finding it means water has been present for a long time. That is a genuine reason to act, and it is a building fact rather than a health verdict. CDC's guidance names no species-specific danger beyond the allergic and respiratory effects of indoor mold generally.
Some molds do produce mycotoxins, and those toxins are real in grain storage and in occupational settings where exposures are much larger. Whether routine household airborne exposure causes systemic illness in otherwise healthy adults is genuinely unsettled in the academic literature, and quantitative extrapolation from swallowed doses to breathed ones is not validated.
The labeled syndromes built on top of that uncertainty are a different matter. Mold Toxicity Syndrome as a clinical entity, and Chronic Inflammatory Response Syndrome with its specific biomarker panel, are not separately validated in the mainstream peer-reviewed literature. That panel has limited independent replication and is not endorsed by the American College of Occupational and Environmental Medicine, the American Academy of Allergy, Asthma and Immunology, or comparable specialty bodies. CDC's mold guidance makes no mention of either as a recognized condition.
The numbered lists that circulate, ten warning signs of mold toxicity and similar, come from those frameworks rather than from the evidence base. No health agency or major evidence review publishes such a list, which is worth knowing before a list decides what you spend.
None of that makes anybody's symptoms imaginary. A checklist collapses two real problems into one. Feeling unwell is a question for a clinician, and a damp home is a question for the moisture. Treating them as one problem tends to leave both unsolved.
Can mold cause fatigue, low mood, or poor sleep?
The evidence here is emerging rather than settled, and it deserves naming honestly in both directions. A 2024 state-of-the-science review in Environmental Health Perspectives found that six of seven adult studies on depression and self-reported mental health reported positive associations with damp or mold-affected housing.
An earlier study of 5,882 adults across eight European cities found depression odds ratios of roughly 1.34 to 1.44 across exposure levels after adjusting for fifteen confounders, though the confidence interval at the most extensive exposure band crosses 1.0.
The limits are as important as the findings, and the review states them itself. Most of this work is cross-sectional, which measures exposure and outcome at the same moment. Exposure is usually self-reported rather than inspected. And reverse causation is plausible: damp housing and hard circumstances travel together, so which one moves first is not established by these designs.
Proposed mechanisms exist without being confirmed, including inflammatory markers, effects on the stress axis, and neuroinflammation. They are candidate explanations in the literature, not a demonstrated pathway.
The signal is real enough to report and not solid enough to diagnose from. If you live somewhere damp and you feel low or tired, both facts deserve attention, and fixing the damp is worth doing on the building's own merits whatever the mental-health question turns out to be.
Why symptoms cannot tell you whether your house has mold
Mold symptoms are not specific to mold, which is the whole problem with reading them backwards. A stuffy nose, a cough, burning eyes, and fatigue are produced by pollen, dust mites, pet allergens, dry winter air, a cold, and a dozen things that are not environmental at all, and EPA has set no federal limit that would let a test settle it either. Read backwards from a symptom to a building and the inference does not hold.
It does not hold in the other direction either, and this is the part that gets lost. A confirmed mold finding in your wall does not establish that it caused what you are feeling. Both statements can be true at once: the growth is real, and the symptom has a different origin.
The structural reason runs deeper than caution. The epidemiology underpinning this entire field uses visual observation of mold or a moldy smell as its measure of exposure, not spore counts, because quantitative exposure assessment in real homes has never been good enough to support one. EPA has set no federal limit for mold or mold spores, because no number would let a test say safe or unsafe.
So a spore count cannot be graded, a symptom cannot be traced backwards, and no test on the market closes the gap between the two. What is left is the pair of questions that actually have answers, asked separately.
The building question has a reliable signal that costs nothing: visible growth plus a source of moisture, in a home that is otherwise well kept. That is what the major agencies converge on, and it is actionable without any laboratory at all.
What to do about the house while a clinician handles the person
Split the two and both become tractable. Take the symptoms to a clinician, who can test the person, and take the building to the water, which is where every mold problem starts and where the fix has to begin. EPA's window is 24 to 48 hours: a surface kept wet that long on material mold can feed on is where growth starts.
On the building side the sequence is fixed. Find what is keeping something wet, correct it, then clean or remove what grew. Under about 10 square feet on a hard surface is homeowner scale once the water is fixed, and porous material that soaked through gets replaced rather than cleaned.
Humidity is the ambient half of the same job. EPA's guidance is to keep indoor humidity below 60 percent, ideally between 30 and 50, and the research consensus tightens the good end of that to 40 to 50 percent. Running above 60 for long stretches supports growth without any leak at all.
On the person side, bring specifics rather than a theory. When the symptoms occur, whether they change when you leave the house for several days, whether anyone in the household has asthma or a known mold allergy, and whether anyone is immunocompromised. A clinician can act on that. So can an allergist, who can test whether you are actually sensitized to what is growing, which is the one thing no building test can answer.
That division is not a way of avoiding the question. It is how each half gets answered by someone equipped to answer it.
Where do I start?
- Take symptoms to a clinician who can test the person, and take the building to the water where every mold problem starts.
- Look for the moisture source before you look for a laboratory. Visible growth plus a source of water is actionable on its own.
- Note whether symptoms ease after several days away from the house, and bring that pattern to your clinician rather than a conclusion.
- Ask an allergist about testing whether you are sensitized to common indoor molds. No building test can answer that.
- Flag anyone in the household with asthma, chronic lung disease, a mold allergy, or a suppressed immune system. Risk is decided by person, not by concentration.
- Keep indoor humidity below 60 percent, ideally 40 to 50, so growth has no ambient moisture to work with.
- Treat a numbered warning-sign list as marketing. No health agency or major evidence review publishes one.
What does the science say?
What actually works?
Common questions
What are the first signs of mold exposure?
A stuffy nose, sore throat, coughing or wheezing, burning eyes, or skin rash, the allergic and respiratory list CDC names directly. People with asthma or a mold allergy react more severely, and people who are immunocompromised can develop lung infections. Every one of those symptoms has many other causes, so they cannot be read backwards to prove a building has mold. The building question is answered by finding visible growth and a source of moisture.
How do you test yourself for mold exposure?
That is a clinical question rather than a home-testing one, and an allergist is the person to ask. What can be tested in a person is sensitization, whether your immune system reacts to particular fungi, which is one of the three things that decide whether a given exposure affects you. No home mold test measures anything about the person: a sample tells you what is growing on a surface, not whether you make antibodies against it. Bring your clinician the pattern, including whether symptoms ease after several days away from the house.
Can black mold kill you?
For a healthy adult in a home, no, and the dramatic claims around black mold are not established in mainstream science. Stachybotrys chartarum matters because it indicates sustained water damage, which is a building fact worth acting on. The serious outcomes documented in the literature are narrower: invasive fungal infection in people whose immune systems are suppressed, and hypersensitivity pneumonitis after repeated exposure to a heavily contaminated system. Both are real, both are uncommon, and neither describes a visible patch in a bathroom.
What are the 10 warning signs of mold toxicity?
There is no validated list of ten warning signs, and no health agency or major evidence review publishes one. Those lists come from mold-illness frameworks rather than the evidence base: Mold Toxicity Syndrome and Chronic Inflammatory Response Syndrome rest on biomarker panels that ACOEM and the American Academy of Allergy, Asthma and Immunology do not endorse, and CDC's guidance mentions neither. What the evidence supports is the airway and allergy symptoms, plus a separate and less settled signal on low mood and fatigue.
Does mold cause fatigue and depression?
The evidence is emerging rather than settled. A 2024 state-of-the-science review found six of seven adult studies reported positive associations between damp or mold-affected housing and depression or self-reported mental health, and an earlier study of 5,882 adults across eight European cities found depression odds ratios around 1.34 to 1.44 after adjusting for fifteen confounders. The limits matter: most of this work is cross-sectional, exposure is usually self-reported, and reverse causation cannot be ruled out. Worth reporting, not enough to diagnose from.
How long does it take to get sick from mold exposure?
No major review publishes a timeline, because it depends on the person rather than the clock. Allergic responses in a sensitized person occur on exposure. Hypersensitivity pneumonitis is a delayed inflammation that follows repeated exposure to a heavily contaminated system rather than a single event. Because sensitization, existing asthma, and susceptibility all vary between individuals, two people in the same room can have different experiences of the same exposure and neither is evidence about the building.
Can mold in your house make you tired?
Possibly, and the evidence for that specific link is weaker than the evidence for the airway symptoms. Peer-reviewed work consistently finds people living in damp, moldy homes report more fatigue, low mood, and poor sleep than people in comparable dry homes, which is a real and repeated finding. It is also mostly cross-sectional and mostly based on self-reported exposure, so it cannot establish direction. Fixing the damp is worth doing on the building's own merits regardless of how that question resolves.
Will symptoms go away after mold is removed?
No published review gives a timeline, and the reason is worth understanding. The epidemiology behind these health effects measures exposure by visible mold and moldy odor rather than by spore counts, so it establishes association between damp homes and symptoms, not a recovery curve for an individual. If symptoms persist after the moisture and the growth are gone, that is information for a clinician, because it suggests the cause may lie somewhere other than the building.
Should I see a doctor for mold exposure?
See one if you feel unwell, and do not wait for a mold test to decide it. A building finding cannot diagnose a person and a symptom cannot diagnose a building, so the two questions go to different places. Bring specifics: when the symptoms occur, whether they ease after several days away from home, and whether anyone in the household has asthma, chronic lung disease, a mold allergy, or a suppressed immune system. An allergist can also test whether you are sensitized to the molds in question.
Sources cited on this page
Every number on this guide page traces to one of the 6 sources below: 4 peer-reviewed, 2 government or regulatory.
Peer-reviewed
- Institute of Medicine, Damp Indoor Spaces and Health, National Academies Press, 2004 (sufficient evidence of association for upper-respiratory symptoms, cough, wheeze, asthma symptoms in sensitized people, hypersensitivity pneumonitis in susceptible individuals; no quantitative safe threshold derivable)
- Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J, Respiratory and Allergic Health Effects of Dampness, Mold, and Dampness-Related Agents, Environ Health Perspect 2011;119(6):748-756 (sufficient evidence for asthma development and exacerbation, cough, wheeze, upper-respiratory symptoms, allergic rhinitis, eczema; asthma exacerbation in children strongly suggestive of causality; explicitly not sufficient evidence of a causal relationship for any reviewed outcome)
- Gatto MR, Mansour A, Li A, Bentley R, A State-of-the-Science Review of the Effect of Damp- and Mold-Affected Housing on Mental Health, Environ Health Perspect 2024;132(8):086001 (six of seven adult studies positive for depression; limits named: 63% cross-sectional, self-reported exposure dominant, reverse causation plausible)
- Shenassa ED, Daskalakis C, Liebhaber A, Braubach M, Brown MJ, Dampness and Mold in the Home and Depression, Am J Public Health 2007;97(10):1893-1899 (N=5,882 adults, eight European cities; depression odds ratios 1.34-1.44 adjusted for 15 confounders; extensive-exposure confidence interval crosses 1.0)
Government & regulatory
- US CDC, Mold information page (stuffy nose, sore throat, coughing or wheezing, burning eyes, skin rash; severe reactions in mold-allergic and asthmatic people; lung infections in the immunocompromised; no recognition of mycotoxin illness or CIRS as clinical conditions)
- US EPA, A Brief Guide to Mold, Moisture, and Your Home (no federal limits for mold or spores; keep indoor humidity below 60 percent, ideally 30 to 50; dry within 24 to 48 hours; under about 10 sq ft is homeowner-scale)
More guides like this one
Curious what you are breathing at home?
Get your free Stasis Score from just your address